Method to reduce connective tissue destruction
US5258371A · kind A · utility
47Cited by
5References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 1992 |
| Grant date | Nov 2, 1993 |
| Priority date | — |
| Expiry date | May 29, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a method of treating humans or animals suffering from a condition or disease characterized by excessive collagen destruction, which comprises administering to said human or animal an effective amount of a 12a-deoxytetracycline represented by the following general formula ##STR1## The method is effective in the treatment of various articular diseases characterized by excessive collagen destruction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.